This results of this study are similar to several previous studies that showed the frequency of CML with BCR-ABL positive are varied, but generally >95% (Goh et al., 2006; Anand et al., 2012; Hansfstein et al., 2014). This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.